Breast cancer and heart disease may have common roots

	Tweet

Women who are at risk for breast cancer may also be at greater risk for heart disease, new research has found.

The majority of women with hereditary breast and ovarian cancer have a mutated form of the BRCA1 or BRCA2 genes, which normally suppress the growth of breast and ovarian tumours.

Dr. Subodh Verma, a cardiac surgeon at St. Michael’s Hospital, said his research team was surprised to discover the genes also regulate heart function.

Following a heart attack, mice with the mutated BRCA1 gene had a three-to-five times higher rate of death. This was largely due to the development of profound heart failure, possibly because their heart attacks were twice as severe as those in mice who did not have the mutated gene.

A similar two-fold increase in heart failure was observed when mice with a mutated BRCA1 or BRAC2 gene were treated with doxorubicin, one of the most common chemotherapy drugs for patients with breast cancer. In addition to studies in mice, the authors also verified this observation in human tissues.

The researchers believe that the mutated BRCA1/2 prevents DNA repair in muscle cells that is essential to recovery after a heart attack.

Their findings were published in the journals Nature Communications and Journal of Biological Chemistry.

“Our findings suggest that individuals who are at risk of breast cancer may also be at a previously unrecognized risk of heart disease,” Dr. Verma said. “More importantly, we now understand that breast cancer and heart disease—the two leading causes of death for Canadian women – have a common biological basis, a common soil.”

Dr. Verma emphasized that these findings may have important implications for patients. Knowing that the BRCA1/2 gene is essential to DNA repair may lead to future treatments for anyone with heart disease, a leading cause of death worldwide. Women who carry this mutated gene now know they may also be at a higher risk for developing heart disease in addition to the risk of developing cancer.

Dr. Christine Brezden-Masley, an oncologist at St. Michael’s and a co-author of the paper, said that while physicians knew doxorubicin was associated with heart failure, the new research shows women with the mutated BRCA1/2 gene are particularly sensitive to its toxicity.

“What this means is that when a patient has the mutated gene, I now have to think about how much doxorubicin I’m going to give them or whether we should consider an alternate therapy,” Dr. Brezden-Masley said.

###

About St. Michael’s Hospital

St. Michael’s Hospital provides compassionate care to all who enter its doors. The hospital also provides outstanding medical education to future health care professionals in more than 23 academic disciplines. Critical care and trauma, heart disease, neurosurgery, diabetes, cancer care, and care of the homeless are among the Hospital’s recognized areas of expertise. Through the Keenan Research Centre and the Li Ka Shing International Healthcare Education Center, which make up the Li Ka Shing Knowledge Institute, research and education at St. Michael’s Hospital are recognized and make an impact around the world. Founded in 1892, the hospital is fully affiliated with the University of Toronto.

###

Leslie Shepherd

416-864-6094
St. Michael’s Hospital

RELATED STORIES:
Breast Cancer and the Environment   FDA OKs Invitrogen genetic test for breast cancer   New technique images tumor vessel leakiness to predict breast cancer chemotherapy outcome   Early-Stage Breast Cancer Patients Lack Knowledge About Their Disease and May Not Receive the Treatment They Prefer   Mammograms under 50 optional for many women   Soy isoflavones may modify risk of breast cancer   Smoking Increases Breast Cancer Risk Based on Genes   Breast symmetry can be early indicator of breast cancer   Detecting breast cancer’s fingerprint in a droplet of blood   Exercise Improves Quality of Life for People with Breast Cancer   Breast cancer subtypes linked to survival from secondary brain tumors   Breast MRI helps predict chemotherapy’s effectiveness   Early detection and improved treatment have contributed almost equally to the substantial decrease i   Breast cancer regimen linked to cognitive decline   Breast asymmetry after cancer treatment affects quality of life, U-M study finds   Study suggests newer breast cancer drug may protect heart   Exercise boosts well-being after breast cancer   Quality of life for younger breast cancer patients more adversely affected than older women   Residual fetal cells in women may provide protection against breast cancer   DCIS patients who get invasive breast cancer have higher mortality   Chemo drugs for treating breast cancer may cause changes in cognitive function   ‘Pink ribbon dollars’ help fill financial gaps for breast cancer programs

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]